What Should Investors Expect From Carter's Ahead of Q2 Earnings?

Carter's (CRI) is poised to report mixed Q2 2025 results, with revenues projected to increase 2.8% to $580 million, fueled by robust baby and toddler demand, international expansion, and strategic pricing initiatives. However, profitability is expected to decline significantly, with EPS forecast to drop 43.4% to 43 cents and operating income down 40.2% to $23.6 million, primarily due to deliberate pricing investments and elevated operating costs. The stock trades at a compelling valuation (9.39x P/E), though Zacks' model does not conclusively predict an earnings beat, and CRI has recently underperformed its industry.

Analysis

Carter's, Inc. (CRI) presents a mixed financial outlook ahead of its Q2 2025 earnings release, characterized by a strategic trade-off between top-line growth and near-term profitability. Revenue is projected to increase 2.8% year-over-year to $580 million, supported by a rebound in comparable sales in April, strong demand in core baby and toddler categories, and robust international and U.S. wholesale growth, expected to rise 6.7% and 7.2% respectively. This sales momentum is being actively driven by deliberate pricing investments, totaling approximately $20 million in the first half of the year, aimed at stimulating traffic and volume. However, this strategy is severely pressuring the bottom line. Consensus estimates point to a 43.4% year-over-year decline in EPS to 43 cents, with projected operating income falling 40.2% to $23.6 million. Margin compression is exacerbated by higher operating costs from digital investments, distribution expenses, and the external risk of potential U.S. tariffs. Despite the company's strong history of earnings surprises, the Zacks model does not predict a beat for the upcoming quarter. This fundamental weakness is reflected in the stock's performance, which has fallen 15.7% in the past three months, starkly underperforming the industry's 24% growth. On a valuation basis, the stock appears compelling, with a forward P/E of 9.39X, a significant discount to its historical high and the industry average of 29.33X.

Key Decisions for Investors

• Investors should weigh the company's success in driving revenue growth of 2.8% against the severe, deliberate margin compression that is forecast to cut EPS by 43.4%, signaling a high-risk growth strategy.
• While the stock's forward P/E of 9.39X appears attractive, the recent 15.7% share price decline against a booming industry suggests the market is already pricing in the significant profitability challenges, warranting caution against viewing it as a simple value play.
• Monitor the Q2 earnings report for any management commentary on the timeline for margin recovery, the impact of the $20 million in pricing investments on consumer behavior, and specific strategies to mitigate potential tariff impacts.
• Given the neutral Zacks model, which does not predict an earnings beat, and the significant bottom-line headwinds, a cautious stance is warranted until there is a clear catalyst for margin expansion.